Healthcare technology outtakes: the untold stories of AI and data-driven innovation

Nearly 9 out of 10 medicines fail to make it to market. Yet, tens of thousands of people go to work every day with a singular goal: to beat these odds, together.
The resilience and persistence of these individuals - working across diverse roles and corners of our ecosystem - lie at the heart of the innovation engine that powers healthcare systems worldwide. Complementing these efforts are government authorities, regulatory bodies, and legislators, whose work in transforming and crafting policies, standards, and frameworks not only safeguards public health but also acts as a critical driver of private sector innovation.

Failure, too, is a dominant and integral feature of fearlessly standing at the forefront of the unknown. Sartre reportedly wrote: "If a victory is told in detail, one can no longer distinguish it from a defeat."

What are the untold details of the great scientific and technological victories of our time - stories we revisit less often, but ought to tell?
What is the role of AI in empowering humans to take bolder risks, leading to the breakthroughs required to transform our health systems in the face of immense challenges: rising demand for healthcare services, workforce shortages, and demographic shifts?

Welcome speech
- Elisabeth Baume-Schneider, Federal Councillor, head of the Federal Department of Home Affairs (FDHA) of Switzerland

Podium speakers
- Noubar Afeyan, founder and chief executive officer, Flagship Pioneering; co-founder and chairman, Moderna
- John Halamka, president, Mayo Clinic Platform, Mayo Clinic
- Edith Heard, general director, European Molecular Biology Laboratory (EMBL), incoming chief executive officer, The Francis Crick Institute
- Martina Hirayama, State Secretary for Education, Research and Innovation, State Secretariat for Education, Research and Innovation (SERI) of Switzerland; closing remarks
- Eric Lohrer, partner, Wyss family office; board, Fondation Beyeler, Wyss Center for Bio and Neuroengineering; Q&A moderator
- Stefan Oelrich, head of Pharmaceuticals Division and board of management, Bayer AG; incoming president, EFPIA; board, Charité
- and others

Moderation
- Mariana Atilano Meriñan, head of strategy & data analytics, Groupe Mutuel

Contact for information, event registration & media requests:
davos@four-corp.com 

To apply to join the session, please visit the session’s webpage.